Adoptive Cell Therapy for T-Cell Malignancies

SIMPLE SUMMARY: Patients with relapsed and refractory T-cell malignancies have poor outlook and limited treatment options. Recently, adoptive cell therapy has emerged as a promising therapy for patients with T-cell malignancies. In this review, we examine the current progress on adoptive cell therap...

Descripción completa

Detalles Bibliográficos
Autores principales: Fang, Karen Kai-Lin, Lee, Jong Bok, Zhang, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9817702/
https://www.ncbi.nlm.nih.gov/pubmed/36612092
http://dx.doi.org/10.3390/cancers15010094

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9817702/
https://www.ncbi.nlm.nih.gov/pubmed/36612092
http://dx.doi.org/10.3390/cancers15010094

Ejemplares similares